Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Role for NGF in Alzheimer's disease?

Oct. 14, 1997

Pierre Fabre discloses potent and selective 5-HT1B receptor antagonists

Oct. 14, 1997

Briana Bio-Tech licenses peptide technology for chronic MS

Oct. 13, 1997

Preclinical data indicate effectiveness of Sertoli cells in neural regeneration

Oct. 13, 1997

Important NRC discovery related to stroke and epilepsy

Oct. 10, 1997

VA-045 effective against TBI-induced retrograde and anterograde amnesia

Oct. 10, 1997

Scios/Wyeth-Ayerst commence large pivotal trials of bFGF for stroke

Oct. 10, 1997

Phase II results for ganaxolone in epilepsy and migraine anticipated by year-end

Oct. 10, 1997

Novel neural antiapoptotic polypeptide discovered by Novartis

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...